Qualigen Therapeutics, Inc.
QLGN
$3.11
$0.103.32%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.85M | -9.72M | -11.60M | -13.42M | -17.34M |
| Total Depreciation and Amortization | 4.50K | 4.50K | 4.50K | 4.50K | 3.00K |
| Total Amortization of Deferred Charges | 736.50K | 1.00M | 1.04M | 1.47M | 1.25M |
| Total Other Non-Cash Items | -3.15M | 854.60K | 860.20K | 527.20K | 7.71M |
| Change in Net Operating Assets | 533.40K | 852.10K | 1.25M | 1.11M | 1.51M |
| Cash from Operations | -9.73M | -7.00M | -8.45M | -10.30M | -6.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -664.60K | 4.81M | 4.41M | 4.22M | 3.74M |
| Cash from Investing | -664.60K | 4.81M | 4.41M | 4.22M | 3.74M |
| Total Debt Issued | 3.48M | 1.48M | 475.00K | -- | 2.90M |
| Total Debt Repaid | -2.11M | -550.00K | -550.00K | -550.00K | -440.00K |
| Issuance of Common Stock | 3.47M | 150.00K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -500.00 |
| Cash from Financing | 4.83M | 1.08M | -75.00K | -550.00K | 2.46M |
| Foreign Exchange rate Adjustments | -- | -115.80K | -160.30K | 0.00 | -4.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -5.56M | -1.23M | -4.28M | -6.64M | -675.80K |
